human blood coagulation factor viii
UkraineDrugs containing this active substance
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency). It can also be used to treat acquired deficiency of this factor.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 500 IU ATC: B02BD02
Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency). It can also be used to treat acquired deficiency of this factor.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 250 IU ATC: B02BD02
Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of coagulation factor VIII). It can also be used to treat acquired deficiency of this factor.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD02
Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (inherited factor VIII deficiency), as well as for the treatment of acquired deficiency of this factor or hemophilia patients with the presence of antibodies (inhibitors).
Form: powder and solvent for infusion solution
Active substance Dosage human blood coagulation factor viii 500 IU ATC: B02BD02
Manufacturer: Kedrion S.p.A.
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (inherited factor VIII deficiency), as well as for the treatment of acquired deficiency of this factor or hemophilia patients with the presence of antibodies (inhibitors).
Form: powder and solvent for infusion solution
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD02
Manufacturer: Kedrion S.p.A.
-
The drug is used for the prevention and treatment of bleeding in patients with von Willebrand disease (if other methods are ineffective) and in hemophilia A. It can also be used to control acquired factor VIII deficiency and to treat patients with the presence of antibodies to this factor.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 250 IU or 50 IU/ml human von willebrand factor 600 IU or 120 IU/mL ATC: B02BD06
-
The drug is used for the prevention and treatment of bleeding in von Willebrand disease (if other methods are ineffective) and in hemophilia A. It may also be used to control acquired factor VIII deficiency.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 500 IU or 50 IU/mL human von willebrand factor 1200 IU or 120 IU/ml ATC: B02BD06
-
The drug is used for the prevention and treatment of bleeding in von Willebrand disease (if other methods are ineffective) and in hemophilia A. It can also be used to control acquired factor VIII deficiency and to treat patients with the presence of anti-factor VIII antibodies.
Form: powder and solvent for solution for injection or infusion
Active substance Dosage human blood coagulation factor viii 1000 IU or 66.6 IU/ml human von willebrand factor 2400 IU or 160 IU/ml ATC: B02BD06
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency) and in von Willebrand disease, if treatment with desmopressin alone is ineffective or contraindicated.
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 250 IU von willebrand factor 190 IU ATC: B02BD06
-
The drug is used for the therapy and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency), as well as in von Willebrand disease, if treatment with desmopressin is ineffective or contraindicated.
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 500 IU von willebrand factor 375 IU ATC: B02BD06
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (due to factor VIII deficiency) and von Willebrand disease (if factor VIII deficiency is present).
Form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 1000 IU von willebrand factor 750 IU ATC: B02BD06
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder for injection solution
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD02
Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder for injection solution
Active substance Dosage human blood coagulation factor viii 250 IU or 500 IU ATC: B02BD02
Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)